Lexaria Bioscience Cash from Financing (TTM) Insights

Lexaria Bioscience Corp (LEXX)

2.35 +0.16 (+7.31%) USD | NASDAQ | Apr 26, 16:00

2.35 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2006. Upgrade now.

Date	Value
February 29, 2024	6.862M
November 30, 2023	3.409M
August 31, 2023	1.590M
May 31, 2023	1.700M
February 28, 2023	-0.0224M
November 30, 2022	-0.0336M
August 31, 2022	-0.0446M
May 31, 2022	3.971M
February 28, 2022	3.971M
November 30, 2021	13.42M
August 31, 2021	13.42M
May 31, 2021	9.326M
February 28, 2021	11.25M
November 30, 2020	1.939M
August 31, 2020	2.654M
May 31, 2020	2.802M
February 29, 2020	2.129M
November 30, 2019	2.390M
August 31, 2019	3.333M
May 31, 2019	3.801M
February 28, 2019	2.890M
November 30, 2018	3.234M
August 31, 2018	1.867M
May 31, 2018	1.437M
February 28, 2018	3.974M

Date	Value
November 30, 2017	4.132M
August 31, 2017	3.996M
May 31, 2017	4.220M
February 28, 2017	1.456M
November 30, 2016	0.6238M
August 31, 2016	0.5143M
May 31, 2016	0.1974M
February 29, 2016	0.559M
November 30, 2015	0.508M
August 31, 2015	0.3733M
May 31, 2015	0.2695M
February 28, 2015	0.8539M
November 30, 2014	0.9339M
July 31, 2014	1.003M
April 30, 2014	1.024M
January 31, 2014	-0.1184M
October 31, 2013	-0.3654M
July 31, 2013	-0.3478M
April 30, 2013	-0.2207M
January 31, 2013	-0.0794M
October 31, 2012	0.2875M
July 31, 2012	0.2654M
April 30, 2012	0.6111M
January 31, 2012	0.5314M
October 31, 2011	0.861M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.0446M

Minimum

Aug 2022

13.42M

Maximum

Aug 2021

4.393M

Average

3.068M

Median

Cash from Financing (TTM) Benchmarks